Influenza Vaccination and Oral Anticoagulant Therapy

• Status: Completed
• Trial end date: 2005-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate INR and INR related index and Warfarin weekly dosage variations after Influenza Vaccination

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Of Perugia
• Treatments: Anticoagulants; Vaccines

Criteria

Inclusion Criteria:

• OA Treatment

• Stable anticoagulation (previous two controls in range)

• Presence of indication for Influenza Vaccination

• Life expectancy > 6 months

• Signed Informed consent

Exclusion Criteria:

• Absence of stable anticoagulation

• Absence of indication for Influenza Vaccination

• Life expectancy < 6 months

• Denied Informed Consent